Piper Sandler Companies (PIPR)

CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure HydrocephalusJune 4, 2026 6:34 AM
PR Newswire (US) Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and MedtronicParticipation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture FundsProceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercializationBoard strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing Series C investorsBOSTON, June 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced it has successfully completed the initial closing of an $85 million Series C financing. Piper Sandler Merchant Banking led the financing with participation from Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds. Proceeds from the financing will fund continued clinical and regulatory development of CereVasc's eShunt System, including the ongoing STRIDE pivotal trial in patients with Normal Pressure Hydrocephalus (NPH). STRIDE is a prospective, multi-center, randomized, controlled trial designed to evaluate the safety and effectiveness of the eShunt System compared to the current standard of care, the ventriculo-peritoneal (VP) shunt, and is intended to support a future Premarket Approval (PMA) submission to the FDA. The company will also advance organizational growth and operational scale-up as it moves toward commercialization.In conjunction with the closing, the company strengthened the Board of Directors with the addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as an independent director and Chair of the Audit Committee, and Tom Schnettler of Piper Sandler Merchant Banking representing the new Series C investors."This Series C financing is a meaningful milestone for CereVasc, and more importantly, for the patients who are living with conditions for which current treatment options remain inadequate," said Dan Levangie, Chairman and Chief Executive Officer of CereVasc. "This funding supports the next critical phase for the eShunt System, including PMA submission and preparation for commercial launch — accelerating our path toward a minimally invasive surgery that we believe has the potential to meaningfully improve patient outcomes and quality of life. We are delighted to welcome a slate of new investors and directors whose experience and conviction will help guide CereVasc through this next phase of growth, and we remain deeply grateful for the continued support of our existing partners."About CereVasc, Inc.
Located in Massachusetts' healthcare hub, CereVasc, Inc. is a clinical-stage medical device company focused on developing novel, minimally invasive treatments for patients with neurological diseases. Its initial product, the eShunt System, employs an innovative percutaneous transvenous-transdural approach to the central nervous system and is intended to enable the first minimally invasive treatment for communicating hydrocephalus (CH). The patented eShunt System includes an endovascularly implantable cerebrospinal fluid shunt and delivery components designed to treat CH without invasive surgery. For additional information, please visit our website at www.cerevasc.com.About Piper Sandler Merchant Banking
Piper Sandler Merchant Banking (PSMB) is the growth equity investment arm of Piper Sandler Companies (NYSE: PIPR). The PSMB team strives to partner with founders and management teams of high potential businesses that can benefit by leveraging Piper Sandler's knowledge, experience, capital and relationships to build market leading enterprises. PSMB provides investment advisory services through the affiliated registered investment adviser, PSC Capital Partners LLC. Learn more about Piper Sandler Merchant Banking.The eShunt System is an investigational device and has not been approved by FDA or any other regulatory agency for commercial sale. Its safety and effectiveness have not yet been fully established.ContactsMedia Contact:
Tiffany Weil
CereVasc, Inc.
tiffanyweil@cerevasc.com View original content to download multimedia:https://www.prnewswire.com/news-releases/cerevasc-inc-announces-over-subscribed-85-million-series-c-financing-to-advance-its-novel-eshunt-system-for-the-treatment-of-normal-pressure-hydrocephalus-302791507.htmlSOURCE CereVasc, Inc. Original: CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per ShareMay 1, 2026 7:30 AM
Business Wire
Piper Sandler Companies (NYSE: PIPR) has released its most recent financial results.


The complete earnings release can be found on the firm’s website at pipersandler.com/earnings.


Join the earnings conference call on Friday, May 1, 2026 at 7:30 a.m. CT.


Dial-in: 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.)

Passcode: 5642050


Access the conference call audio webcast.


A playback of the call will be available at pipersandler.com/earnings approximately three hours after the event.


ABOUT PIPER SANDLER


Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.


Follow Piper Sandler: LinkedIn | Facebook | Twitter


©2026. Since 1895. Piper Sandler Companies. 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401

View source version on businesswire.com: https://www.businesswire.com/news/home/20260501128015/en/
Kate Clune

Chief Financial Officer

Piper Sandler

Tel: 212 466-7799

investorrelations@psc.com


Original: Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

Piper Sandler Companies to Announce First Quarter 2026 Financial Results and Host a Conference Call on May 1, 2026April 21, 2026 12:00 PM
Business Wire
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its first quarter 2026 financial results prior to the opening of the market on Friday, May 1, 2026. The earnings release will be available at the company’s website at pipersandler.com/earnings.


Chad Abraham, chairman and chief executive officer; Deb Schoneman, president; and Kate Clune, chief financial officer, will host a related conference call at 8:30 a.m. ET (7:30 a.m. CT) that same day to review the financial results. There will be a question and answer session following the review.


Investors and analysts may participate in the live conference call by dialing 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) and passcode 5642050. Please dial in at least 15 minutes prior to the call time.


A live audio webcast of the conference call will be available through the company’s website at pipersandler.com/earnings. A replay of the conference call will be available after the event through the same link.


Please direct any questions regarding obtaining access to the conference call to Piper Sandler Investor Relations, via email, at investorrelations@psc.com.


ABOUT PIPER SANDLER


Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.


© 2026. Since 1895. Piper Sandler Companies. 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401

View source version on businesswire.com: https://www.businesswire.com/news/home/20260421309773/en/
Kate Clune

Tel: 212 466-7799

investorrelations@psc.com


Original: Piper Sandler Companies to Announce First Quarter 2026 Financial Results and Host a Conference Call on May 1, 2026

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason ArnoldFebruary 23, 2026 4:00 AM
Business Wire
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions.


“We’re delighted to welcome Jason to the healthcare investment banking team. He brings extensive experience advising executives and boards across the tools and diagnostics landscape, both in Europe and globally. His perspective and relationships will further strengthen our ability to deliver strategic advice to clients worldwide,” said Peter Day, global group head of healthcare investment banking at Piper Sandler.


"I’m excited to join the global healthcare investment banking team, given its deep sector expertise and broad engagement across the healthcare ecosystem. I look forward to working with my partners to provide global clients with unique market insights and access to the firm’s leading platform, building on its strong foundation in life science tools and diagnostics to help clients execute complex strategic and capital markets decisions with confidence," said Arnold.


Prior to joining Piper Sandler, Arnold was a partner and managing director at William Blair, where he spent 16 years in its healthcare investment banking group. He began his career at Ernst & Young. Arnold received a bachelor’s degree and a master’s degree from the University of Colorado, Boulder.


ABOUT PIPER SANDLER


Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.


Follow Piper Sandler: LinkedIn | Facebook | X


©2026. Since 1895. Piper Sandler Companies. 350 North 5th Street Minneapolis, MN 55401-5711

View source version on businesswire.com: https://www.businesswire.com/news/home/20260223201916/en/
Nick Lawler

Tel: 212 891-8954

nick.lawler@psc.com


Original: Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

Piper Sandler posts record Q4 revenue, smashes earnings forecastsFebruary 6, 2026 10:32 AM
IH Market News
Piper Sandler Companies (NYSE:PIPR) reported a standout fourth quarter for 2025 on Friday, delivering adjusted earnings and revenue that came in well ahead of market expectations and capped a record year for the investment bank.Adjusted earnings reached $6.88 per share for the quarter, comfortably beating analyst estimates of $4.73. Revenue climbed to an all-time high of $666.1 million, far above the consensus forecast of $518.1 million. Despite the strong numbers, the company’s shares slipped 0.49% in pre-market trading.The fourth quarter marked Piper Sandler’s strongest period on record, with revenue rising 38% year over year and 39% sequentially. Advisory services were the main growth engine, with revenue jumping 44% year over year to $402.6 million. Financial services activity remained strong, while the services and industrials team delivered a record quarter. The firm completed 127 advisory transactions during the period, up 38% from a year earlier.“We had a fantastic finish to 2025, delivering record fourth quarter revenues. Full year revenues of $1.9 billion grew over 20% fueled by a record year from our advisory business, and strong growth across the rest of our businesses,” said Chad Abraham, chairman and chief executive officer.For the full year 2025, Piper Sandler reported adjusted earnings of $17.74 per share on revenue of $1.9 billion, representing year-over-year increases of 40% and 22%, respectively. Adjusted operating margin improved to 27.2% in the fourth quarter, up from 24.4% in the same period last year.The board announced a special cash dividend of $5.00 per share alongside a regular quarterly dividend of $0.70 per share. The company also revealed plans for a 4-for-1 stock split, effective March 24, 2026, aimed at boosting liquidity and broadening investor access.Across business lines, corporate investment banking revenue for 2025 rose 28% compared with the prior year, while institutional brokerage revenue increased 8%, supported by record performance in equity brokerage.Piper Sandler Companies stock price

Original: Piper Sandler posts record Q4 revenue, smashes earnings forecasts

Piper Sandler Companies Reports Fourth Quarter and Full Year 2025 Results; Declares Special Dividend of $5.00 Per Share and Quarterly Dividend of $0.70 Per Share; Announces 4-for-1 Stock SplitFebruary 6, 2026 7:00 AM
Business Wire
Piper Sandler Companies (NYSE: PIPR) has released its most recent financial results.


The complete earnings release can be found on the firm’s website at pipersandler.com/earnings.


Join the earnings conference call on Friday, February 6, 2026, at 7:00 a.m. CT.


Dial-in: 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.)

Passcode: 3387875.


Access the conference call audio webcast.


A playback of the call will be available at pipersandler.com/earnings approximately three hours after the event.


For additional information on the stock split, please visit the Shareholder Information page on our website.


ABOUT PIPER SANDLER


Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | Twitter


©2026. Since 1895. Piper Sandler Companies. 350 North 5th Street, Minneapolis, Minnesota 55401-5711

View source version on businesswire.com: https://www.businesswire.com/news/home/20260206217278/en/
Kate Clune

Chief Financial Officer

Piper Sandler

Tel: 212 466-7799

investorrelations@psc.com


Original: Piper Sandler Companies Reports Fourth Quarter and Full Year 2025 Results; Declares Special Dividend of $5.00 Per Share and Quarterly Dividend of $0.70 Per Share; Announces 4-for-1 Stock Split

PIPR new 52 week high

PIPR YTD